218 related articles for article (PubMed ID: 6304026)
1. [3H]nitrendipine receptors in skeletal muscle.
Fosset M; Jaimovich E; Delpont E; Lazdunski M
J Biol Chem; 1983 May; 258(10):6086-92. PubMed ID: 6304026
[TBL] [Abstract][Full Text] [Related]
2. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates.
Galizzi JP; Fosset M; Lazdunski M
Eur J Biochem; 1984 Oct; 144(2):211-5. PubMed ID: 6092067
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling.
Renaud JF; Kazazoglou T; Schmid A; Romey G; Lazdunski M
Eur J Biochem; 1984 Mar; 139(3):673-81. PubMed ID: 6321185
[TBL] [Abstract][Full Text] [Related]
4. [3H] verapamil binding sites in skeletal muscle transverse tubule membranes.
Galizzi JP; Fosset M; Lazdunski M
Biochem Biophys Res Commun; 1984 Jan; 118(1):239-45. PubMed ID: 6696758
[TBL] [Abstract][Full Text] [Related]
5. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.
Bolger GT; Skolnick P
Br J Pharmacol; 1986 Aug; 88(4):857-66. PubMed ID: 3017494
[TBL] [Abstract][Full Text] [Related]
6. Solubilization of the nitrendipine receptor from skeletal muscle transverse tubule membranes. Interactions with specific inhibitors of the voltage-dependent Ca2+ channel.
Borsotto M; Norman RI; Fosset M; Lazdunski M
Eur J Biochem; 1984 Aug; 142(3):449-55. PubMed ID: 6088224
[TBL] [Abstract][Full Text] [Related]
7. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
8. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
Kanngiesser U; Pongs O
Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
[TBL] [Abstract][Full Text] [Related]
9. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules.
Kirley TL; Schwartz A
Biochem Biophys Res Commun; 1984 Aug; 123(1):41-9. PubMed ID: 6089800
[TBL] [Abstract][Full Text] [Related]
10. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
11. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
[TBL] [Abstract][Full Text] [Related]
12. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.
Campbell KP; Sharp A; Strom M; Kahl SD
Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317
[TBL] [Abstract][Full Text] [Related]
13. Identification of calcium antagonist receptor binding sites using (3H)nitrendipine in bovine tracheal smooth muscle membranes.
Cheng JB; Bewtra A; Townley RG
Experientia; 1984 Mar; 40(3):267-9. PubMed ID: 6321228
[TBL] [Abstract][Full Text] [Related]
14. Solubilization of the calcium antagonist receptor from rat brain.
Curtis BM; Catterall WA
J Biol Chem; 1983 Jun; 258(12):7280-3. PubMed ID: 6305932
[TBL] [Abstract][Full Text] [Related]
15. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
Galizzi JP; Fosset M; Lazdunski M
Biochem Biophys Res Commun; 1985 Oct; 132(1):49-55. PubMed ID: 2998366
[TBL] [Abstract][Full Text] [Related]
17. [3H]nitrendipine receptors as markers of a class of putative voltage-sensitive Ca2+ channels in normal human skeletal muscle and in muscle from Duchenne muscular dystrophy patients.
Desnuelle C; Renaud JF; Delpont E; Serratrice G; Lazdunski M
Muscle Nerve; 1986 Feb; 9(2):148-51. PubMed ID: 2419753
[TBL] [Abstract][Full Text] [Related]
18. Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla.
Ballesta JJ; Garcia AG; Gutierrez LM; Hidalgo MJ; Palmero M; Reig JA; Viniegra S
Br J Pharmacol; 1990 Sep; 101(1):21-6. PubMed ID: 1704272
[TBL] [Abstract][Full Text] [Related]
19. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
Bolger GT; Marcus KA; Daly JW; Skolnick P
J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
[TBL] [Abstract][Full Text] [Related]
20. A novel high affinity class of Ca2+ channel blockers.
Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]